CVE-2019-18248

Description

BIOTRONIK CardioMessenger II, The affected products transmit credentials in clear-text prior to switching to an encrypted communication channel. An attacker can disclose the product’s client credentials for connecting to the BIOTRONIK Remote Communication infrastructure.

Category

4.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.03%
Third-Party Advisory us-cert.gov
Affected: n/a BIOTRONIK CardioMessenger II-S T-Line, CardioMessenger II-S GSM
Published at:
Updated at:

References

Link Tags
https://www.us-cert.gov/ics/advisories/icsma-20-170-05 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2019-18248?
CVE-2019-18248 has been scored as a medium severity vulnerability.
How to fix CVE-2019-18248?
To fix CVE-2019-18248, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-18248 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2019-18248 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-18248?
CVE-2019-18248 affects n/a BIOTRONIK CardioMessenger II-S T-Line, CardioMessenger II-S GSM.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.